A general piece on what a Lilly price cut means for patients and the points to consider, with no specific figures given.
Recap by typeshit. Full story at emy.
New Zealand's cardiovascular advisory committee rated it a high priority. Wegovy is used there now but patients pay the full cost themselves.
A rule in Ohio's administrative code blocks Medicaid from covering the drugs for obesity in adults, though teens under 18 are covered under federal law.
Health minister Dzulkefly says the government did not set aside dedicated 2026 budget funds for the two GLP-1 treatments.
Sales missed forecasts by about $33 million, but Lilly says demand more than tripled. Novo's Wegovy pill still holds roughly 75% of oral GLP-1 scripts.
The paid report tracks more than 50 peptide conjugates in clinical trials and 18 proprietary platforms, with most activity in cancer.
A general guide to tirzepatide, covering what it is used for and the safety points EMY says patients should know.
Loading…